Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Study sponsor: Delcath Systems Inc. · DCTH
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2026-12Estimated
Enrollment · participants90Estimated
Source updated2026-10-20Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.